Puylaert Kevin (CIK 2119354) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell SOPH (138 shares), Sell SOPH (47 shares), Sell SOPH (31 shares), Sell SOPH (33 shares), Sell SOPH (33 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 138 | $693 |
| 2026-07-07 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 47 | $236 |
| 2026-07-07 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 31 | $158 |
| 2026-05-20 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 33 | $150 |
| 2026-04-21 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 33 | $168 |
| 2026-04-08 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 548 | $2,663 |
| 2026-04-08 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Buy | 56,468 | $0 |
| 2026-04-08 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 46 | $224 |
| 2026-04-08 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 30 | $145 |
| 2026-04-03 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Buy | 56,468 | $0 |
| 2026-03-20 | SOPHiA GENETICS SA (SOPH) | Chief Sales Officer | Sell | 33 | $157 |
Source: SEC Form 4 filings · as of 2026-07-07